1 / 16

Adam David Gracz

NF2/Merlin Normal Functions and implications in cancer biology. Adam David Gracz. Normal Function. Tumor Suppressor. NF2 = gene Merlin = protein…a.k.a. schwannomin. Tumor suppressive ability comes from partial inhibition of Ras/Rac signaling (phosphorylates in the presence of Ras/Rac).

chavez
Télécharger la présentation

Adam David Gracz

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. NF2/Merlin Normal Functions and implications in cancer biology Adam David Gracz

  2. Normal Function Tumor Suppressor • NF2 = gene • Merlin = protein…a.k.a. schwannomin • Tumor suppressive ability comes from partial inhibition of Ras/Rac signaling (phosphorylates in the presence of Ras/Rac).

  3. Normal Function • Similar to ERM family of proteins : membrane-cytoskeleton linking proteins • Strong evidence of a role in cell motility and proliferation Sun, et. al. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. Journal of Cell Science 2002: 115, 3991-4000

  4. Normal Function Sun, et. al. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. Journal of Cell Science 2002: 115, 3991-4000 • Is considered functionally active in “closed” state – N- (FERM domain) and • COOH-terminals self-associate. • Serine phosphorylation at COOH-terminus prevents self-association, Merlin • is in “open state” and therefore functionally inactive.

  5. Normal Function • Helps regulate signaling in RhoGTPases (Rho, Rac, and Cdc42). These factors • control cell motility and matrix adhesions. Sun, et. al. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. Journal of Cell Science 2002: 115, 3991-4000

  6. What goes wrong • Neurofibromatosis type II is autosomal dominant • Follows Knudson’s “two-hit” hypothesis: • One allelic mutation from parent • One somatic allelic mutation

  7. What goes wrong • Loss of function also observed in sporadic tumors (i.e. non-neurofibromatosis type II patients). • Proposed model of tumor suppressive function involves phosphorylation • of Merlin by kinase cascade initiated through Rho/Rac

  8. What goes wrong Sun, et. al. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. Journal of Cell Science 2002: 115, 3991-4000

  9. What goes wrong Increased cell growth/survival/motility! Sun, et. al. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. Journal of Cell Science 2002: 115, 3991-4000

  10. Finding NFR2 • Mouse models that are doubly deficient of NF2 (genotype NF2-/-) exhibit lethality in the embryonic stage (days 6.5-7: high specificity). Wild-type Homozygous mutant McClatchey, et al. The Nf2 tumor suppressor gene product is essential for extraembryonic development immediately prior to gastrulation. Genes & Dev. 1997 11: 1253-1265

  11. Finding NFR2 • Mouse models with one mutated allele of NF2 (genotype NF2+/-) exhibit extensive, multi-systemic tumors with a high rate of metastasis.

  12. Finding NFR2 • Tissue deficient of Merlin loses ability to form cadherin mediated • cell-cell junctions. McClatchey, Merlin and ERM proteins: unappreciated roles in cancer development? Nature Reviews Cancer Nov. 2003 877-883 • Cells expressing aberrant Ras exhibit contact inhibition. This • property can be “rescued” by the addition of wild-type Merlin.

  13. Clinical Presentations Classic manifestation = MISME: Multiple Inherited Schwannomas, Meningiomas, Ependymomas Bilateral Vestibular Schwannoma (Acoustic neuroma) Xiao, et. al. Chinese Medical Journal, 2007, Vol. 120 No. 16 : 1456-1459 Meningioma Tuburculum Sella Meningioma: http://www.cornellneurosurgery.org/endoscopicskullbase/Meningiomas.htm

  14. Clinical Presentations Spinal ependymoma – intradural-extramedullary Mesothelioma Ependymoma of the Lumbar Spine: http://www.columbiaspine.org/patients/disease/spinal_tumors.html History: Cough: http://www.radiology.vlahos.org/45391/47473.html

  15. Therapies and Outlook • Observation if tumors diagnosed early • Cochlear implants to compensate for hearing loss (vestibular schwannomas) • Surgical resection or decompression • Stereotactic radiosurgery

  16. Therapies and Outlook • Clinical trial for vatalanib in progress at Northwestern University: -patient must be an adult -works as a protein tyrosine kinase inhibitor targeting tumor angiogenesis – nonspecific to NF2/Merlin • Precise pathway and interaction with other signaling cascades remains unclear.

More Related